These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31418046)

  • 1. Quality of life in patients with limited (1-3) brain metastases undergoing stereotactic or whole brain radiotherapy : A prospective study of the DEGRO QoL working group.
    Steinmann D; Vordermark D; Gerstenberg W; Aschoff R; Gharbi N; Müller A; Schäfer C; Theodorou M; Wypior HJ; Geinitz H;
    Strahlenther Onkol; 2020 Jan; 196(1):48-57. PubMed ID: 31418046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life in patients with brain metastases using the EORTC QLQ-BN20+2 and QLQ-C15-PAL.
    Caissie A; Nguyen J; Chen E; Zhang L; Sahgal A; Clemons M; Kerba M; Arnalot PF; Danjoux C; Tsao M; Barnes E; Holden L; Danielson B; Chow E
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1238-45. PubMed ID: 22172909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective evaluation of quality of life effects in patients undergoing palliative radiotherapy for brain metastases.
    Steinmann D; Paelecke-Habermann Y; Geinitz H; Aschoff R; Bayerl A; Bölling T; Bosch E; Bruns F; Eichenseder-Seiss U; Gerstein J; Gharbi N; Hagg J; Hipp M; Kleff I; Müller A; Schäfer C; Schleicher U; Sehlen S; Theodorou M; Wypior HJ; Zehentmayr F; van Oorschot B; Vordermark D
    BMC Cancer; 2012 Jul; 12():283. PubMed ID: 22780988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life after whole brain radiotherapy compared with radiosurgery of the tumor bed: results from a randomized trial.
    Kepka L; Tyc-Szczepaniak D; Osowiecka K; Sprawka A; Trąbska-Kluch B; Czeremszynska B
    Clin Transl Oncol; 2018 Feb; 20(2):150-159. PubMed ID: 28616720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole brain radiotherapy versus stereotactic radiosurgery for 4-10 brain metastases: a phase III randomised multicentre trial.
    Zindler JD; Bruynzeel AME; Eekers DBP; Hurkmans CW; Swinnen A; Lambin P
    BMC Cancer; 2017 Jul; 17(1):500. PubMed ID: 28743240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of radiotherapy for brain metastases on quality of life (QoL). Prospective pilot study of the DEGRO QoL working party.
    Steinmann D; Schäfer C; van Oorschot B; Wypior HJ; Bruns F; Bölling T; Sehlen S; Hagg J; Bayerl A; Geinitz H; Hipp M; Vordermark D
    Strahlenther Onkol; 2009 Mar; 185(3):190-7. PubMed ID: 19330297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatigue scores in patients with brain metastases receiving whole brain radiotherapy.
    Pulenzas N; Khan L; Tsao M; Zhang L; Lechner B; Thavarajah N; Barnes E; Danjoux C; Holden L; Lauzon N; Sheehan P; Bedard G; Chow E
    Support Care Cancer; 2014 Jul; 22(7):1757-63. PubMed ID: 24510194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proxy assessment of patients before and after radiotherapy for brain metastases. Results of a prospective study using the DEGRO brain module.
    Steinmann D; Vordermark D; Geinitz H; Aschoff R; Bayerl A; Gerstein J; Hipp M; van Oorschot B; Wypior HJ; Schäfer C
    Strahlenther Onkol; 2013 Jan; 189(1):47-53. PubMed ID: 23161120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.
    Chang EL; Wefel JS; Hess KR; Allen PK; Lang FF; Kornguth DG; Arbuckle RB; Swint JM; Shiu AS; Maor MH; Meyers CA
    Lancet Oncol; 2009 Nov; 10(11):1037-44. PubMed ID: 19801201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical Trial.
    Palmer JD; Klamer BG; Ballman KV; Brown PD; Cerhan JH; Anderson SK; Carrero XW; Whitton AC; Greenspoon J; Parney IF; Laack NNI; Ashman JB; Bahary JP; Hadjipanayis CG; Urbanic JJ; Barker FG; Farace E; Khuntia D; Giannini C; Buckner JC; Galanis E; Roberge D
    JAMA Oncol; 2022 Dec; 8(12):1809-1815. PubMed ID: 36264568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal clinically important differences in the EORTC QLQ-BN20 in patients with brain metastases.
    Wong E; Zhang L; Kerba M; Arnalot PF; Danielson B; Tsao M; Bedard G; Thavarajah N; Cheon P; Danjoux C; Pulenzas N; Chow E
    Support Care Cancer; 2015 Sep; 23(9):2731-7. PubMed ID: 25663577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
    Xue J; Kubicek GJ; Grimm J; LaCouture T; Chen Y; Goldman HW; Yorke E
    J Neurosurg; 2014 Dec; 121 Suppl():60-8. PubMed ID: 25434938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole Brain Irradiation or Stereotactic RadioSurgery for five or more brain metastases (WHOBI-STER): A prospective comparative study of neurocognitive outcomes, level of autonomy in daily activities and quality of life.
    Ferini G; Viola A; Valenti V; Tripoli A; Molino L; Marchese VA; Illari SI; Rita Borzì G; Prestifilippo A; Umana GE; Martorana E; Mortellaro G; Ferrera G; Cacciola A; Lillo S; Pontoriero A; Pergolizzi S; Parisi S
    Clin Transl Radiat Oncol; 2022 Jan; 32():52-58. PubMed ID: 34926839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient reported outcomes following whole brain radiotherapy in patients with brain metastases in NSIA-LUTH Cancer Center.
    Adegboyega B; Joseph A; Alabi A; Omomila J; Ngema LM; Ainsworth V; Chin J; Evbuomwan MO; Ngwa W
    BMC Cancer; 2023 Dec; 23(1):1233. PubMed ID: 38098061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of WBRT alone, SRS alone, and their combination in the treatment of one or more brain metastases: Review and meta-analysis.
    Khan M; Lin J; Liao G; Li R; Wang B; Xie G; Zheng J; Yuan Y
    Tumour Biol; 2017 Jul; 39(7):1010428317702903. PubMed ID: 28675121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hair-sparing whole brain radiotherapy with volumetric arc therapy in patients treated for brain metastases: dosimetric and clinical results of a phase II trial.
    De Puysseleyr A; Van De Velde J; Speleers B; Vercauteren T; Goedgebeur A; Van Hoof T; Boterberg T; De Neve W; De Wagter C; Ost P
    Radiat Oncol; 2014 Jul; 9():170. PubMed ID: 25074394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I/II Dose-Escalation Trial of 3-Fraction Stereotactic Radiosurgery for Resection Cavities From Large Brain Metastases: Health-related Quality of Life Outcomes.
    Rahimy E; Dudley SA; von Eyben R; Pollom EL; Seiger K; Modlin L; Wynne J; Fujimoto D; Jacobs LR; Chang SD; Gibbs IC; Hancock SL; Adler JR; Li G; Choi CYH; Soltys SG
    Am J Clin Oncol; 2021 Nov; 44(11):588-595. PubMed ID: 34670228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results.
    Soffietti R; Kocher M; Abacioglu UM; Villa S; Fauchon F; Baumert BG; Fariselli L; Tzuk-Shina T; Kortmann RD; Carrie C; Ben Hassel M; Kouri M; Valeinis E; van den Berge D; Mueller RP; Tridello G; Collette L; Bottomley A
    J Clin Oncol; 2013 Jan; 31(1):65-72. PubMed ID: 23213105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early whole brain radiotherapy in primary CNS lymphoma: negative impact on quality of life in the randomized G-PCNSL-SG1 trial.
    Herrlinger U; Schäfer N; Fimmers R; Griesinger F; Rauch M; Kirchen H; Roth P; Glas M; Bamberg M; Martus P; Thiel E; Korfel A; Weller M
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1815-1821. PubMed ID: 28434043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life among patients with 4 to 10 brain metastases after treatment with whole-brain radiotherapy vs. stereotactic radiotherapy: a phase III, randomized, Dutch multicenter trial.
    Hartgerink D; Bruynzeel A; Eekers D; Swinnen A; Hurkmans C; Wiggenraad R; Swaak-Kragten A; Dieleman E; van der Toorn PP; van Veelen L; Verhoeff JJC; Lagerwaard F; de Ruysscher D; Lambin P; Zindler J
    Ann Palliat Med; 2022 Apr; 11(4):1197-1209. PubMed ID: 34806396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.